Focus

Primordial Genetics Inc. has developed Function Generator™, a novel combinatorial gain-of-function genetic technology designed to enhance productivities of microbes used for the production of proteins (therapeutic proteins, industrial enzymes) and chemicals / fuels / pharmaceuticals. Function Generator™ has been validated in baker’s yeast (Saccharomyces cerevisiae) and the laboratory bacterium Escherichia coli.

Target

Microbes are widely used for bio-production. Genetic optimization – creating improved strains of microbes for maximum efficiency and productivity – is currently difficult, slow and expensive. Function Generator™ is capable of dramatic improvement of productivities, tolerances and growth characteristics in production organisms to achieve economic and sustainable biological production systems.

Market

The company is seeking partnerships to apply this promising genetic technology to improving industrial production organisms and systems in a variety of industries: pharmaceuticals, renewable chemicals & fuels, food processing and agricultural biotechnology. Our internal R&D is focused on producing superior E. coli strains for protein production.

Goal

Primordial Genetics is working to become a leading provider of genetic solutions for microbial improvement. Our ultimate goal is to be able to shape the genetics and characteristics of useful organisms rapidly and flexibly – like clay in our hands.

Building Better Microbes with Function Generator

Cost Reduction

    Reduction in R&D cost
    Lower commercial CAPEX and OPEX
    Accelerated production runs translating into higher production capacity
    Design flexibility due to use of inexpensive production hosts

High Efficacy

    Improved protein solubility & expression
    Increased product titers and yields
    Enhanced growth and stress/product tolerances
    Improved enzymes and trait genes

Time Savings

    Accelerated strain development
    Transferable traits encoded by single genes
    Higher phenotypic gain per improvement cycle
    50-75% reduction in commercial strain development time

Novel Products

    Therapeutic proteins
    Industrial enzymes
    Trait genes
    New IP and FTO

Function Generator™ has been validated in baker’s yeast (Saccharomyces cerevisiae) and the laboratory bacterium Escherichia coli. The company is seeking partnerships to apply this promising genetic technology to improving industrial production organisms and systems. Our internal R&D is focused on producing superior E. coli strains for protein production.

Traditional methods vs Primordial Genetics methods